Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arun Menawat Insider Profile
11 Followers
Arun Menawat, Senior Officer at Novadaq, holds 563.45K shares in Profound Medical (Ticker: TSE:PRN), holds 564.66K shares in Novadaq (Ticker: ~NVDQ). Most recently, Arun Menawat Bought ― shares of Profound Medical on Dec 11, 2024 for an estimated value of 150.00K.
Profitable Transactions
11 out of 26 Profitable Transactions
Average Return
+13.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chairman & Chief Executive Officer
Roles that Arun Menawat holds in companies
Most Profitable Insider Trade
The most profitable trade made by Arun Menawat
Arun Menawat's Trading History
Novadaq
Apr 13, 2016
―
Uninformative Buy
―
$6.63M
Profound Medical
Dec 11, 2024
Chairman & Chief Executive Officer
Informative Buy
150.00K
C$5.82M
List of latest transactions for each holding click on a transaction to see Arun Menawat's performance on stock
You May Also Like
Arun Menawat insider profile FAQ
What is the percentage of profitable transactions made by Arun Menawat?
The percentage of profitable transactions made by Arun Menawat is 42%.
What is the average return per transaction made by Arun Menawat?
The average return per transaction made by Arun Menawat is 13.70%.
What stocks does Arun Menawat hold?
Arun Menawat holds: ~NVDQ, TSE:PRN stocks.
What was Arun Menawat’s latest transaction?
Arun Menawat latest transaction was an Informative Buy of C$150.00K.
What was Arun Menawat's most profitable transaction?
Arun Menawat’s most profitable transaction was an Informative Buy of TSE:PRN stock on May 14, 2022. The return on the trade was 102.80%.
What is Arun Menawat's role in Novadaq?
Arun Menawat's role in Novadaq is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.